Global Preimplantation Genetic Diagnosis (PGD) Market to Earn US $118.0 Mn with Rise in Infertility Causing Delayed Conception
The global preimplantation genetic diagnosis (PGD) market is foreseen to find companies constantly endeavoring to upgrade their genetic testing technology, so they could offer improved services to healthcare professionals and increase efficiency. It marks the presence of some of the top players of the industry, including Laboratory Corporation of America Holdings, Natera, Inc., Genea Ltd., Illumina, Inc., and Genesis Genetics Ltd. In a report by Transparency Market Research (MRRSE), the competitive landscape of the market has been analyzed in great...
View full press release